Eurand to Present at Barclays Capital Global Healthcare Conference
March 10 2010 - 8:45AM
Marketwired
Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical
company, announced today that it is scheduled to present at the
upcoming Barclays Capital 2010 Global Healthcare Conference.
Gearoid Faherty, Eurand's Chairman and Chief Executive Officer,
will be presenting.
Date: Wednesday, March 24, 2010
Time: 10:15 a.m. ET
Location: Loews Hotel, Miami, Fla.
An audio webcast of the presentation will be available by
accessing the investor relations section of Eurand's website at
www.eurand.com. A replay of the presentation will be available for
30 days.
About Eurand
Eurand is a specialty pharmaceutical company that develops,
manufactures and commercializes enhanced pharmaceutical and
biopharmaceutical products based on its proprietary pharmaceutical
technologies. Eurand has had six products approved by the FDA since
2001 and has a pipeline of product candidates in development for
itself and its collaboration partners. Its technology platforms
include bioavailability enhancement of poorly soluble drugs, custom
release profiles and taste-masking/ orally disintegrating tablet
(ODT) formulations. Eurand is a global company with facilities in
the U.S. and Europe. For more information, visit
www.eurand.com.
Contacts: Bill Newbould Vice President, Investor
Relations Eurand N.V. +1 267-759-9335 Email Contact Nick
Laudico/Sara Pellegrino The Ruth Group +1 646-536-7030/7002 Email
Contact Email Contact
Eurand N.V. (MM) (NASDAQ:EURX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Eurand N.V. (MM) (NASDAQ:EURX)
Historical Stock Chart
From Jul 2023 to Jul 2024